Wichita County authorizes judge to sign opioid MDL participation forms for multiple settlements

5833901 · September 3, 2025

Get AI-powered insights, summaries, and transcripts

Subscribe
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

After a closed-session briefing on opioid litigation, the court voted 5-0 to authorize the county judge to execute participation forms for settlements involving Purdue and a group of other manufacturers and distributors in the national prescription opioid MDL (117-MD-02804).

Following a closed-session briefing, Wichita County Commissioners Court returned to open session Sept. 2 and authorized the county judge to execute participation forms for proposed settlements in the national prescription opioid multidistrict litigation (MDL number 117-MD-02804). The authorization covers two groups: 1) Purdue and certain of its affiliates related to the Sackler family, and 2) a group listing other manufacturers and distributors referenced in the motion (transcript text lists "Alvogen, Amneal, Apotel, Hikma, Indivior, Mylan, Sun and Zydus" among parties). The court’s action followed a closed-session consultation with counsel under Texas Government Code section 552.071. A motion to authorize the county judge to execute the participation forms was made and seconded; the court voted 5-0 in open session to approve the authorization. No further contract language or monetary terms were read into the record during the open session; the court recorded the authorization to sign the forms as the formal action. The closed-session notice on the agenda identified the topics as settlement terms related to Purdue and a list of other companies; commissioners did not disclose settlement amounts or specific contract conditions in open session during the motion.